HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dual-specificity phosphatase Pyst2-L is constitutively highly expressed in myeloid leukemia and other malignant cells.

Abstract
Northern blotting confirmed previous results indicating that the mitogen-activated protein kinase (MAPK) phosphatase Pyst2-L was highly expressed in leukocytes obtained from acute myeloid leukemia (AML) patients. High levels of Pyst2-L mRNA were expressed in bone marrow (BM) and peripheral leukocytes from nine AML and acute lymphoblastic leukemia (ALL) patients. BM from healthy individuals expressed very low levels of Pyst2-L. Whereas high levels of Pyst2-L mRNA and protein were detected in several leukemia cell lines, Pyst2-L mRNA was detected neither in 33/34 samples of normal peripheral blood mononuclear cells (PBMC) nor in leukocyte fractions enriched with CD34+ cells. Certain solid tumor and lymphoblastoid cell lines expressed high levels of Pyst2-L mRNA. In view of the association of Pyst2-L to MAPK signaling cascades, we tested if cell activation, a process involving MAPK signaling, influences Pyst2-L expression. Indeed, activation of T cells and endothelial cells increased Pyst2-L in these cells. Furthermore, TPA, a known MAPK activator, induces the expression of both Pyst2-L mRNA as well as the Pyst2-L protein in leukemia cells. This induction was partially inhibited by PD098059, an Mek1/2-specific inhibitor. Based on the results of this and previous studies, we hypothesize that the high levels of Pyst2-L detected in the active state of AML and ALL diseases and in other types of cancer reflect an altered MAPK signaling pathway in such malignant processes. This alteration may be the result of a failed attempt to counter the constitutive activation of MAPK in transformed cells or alternatively, may represent the activated state of such cells.
AuthorsOrlev Levy-Nissenbaum, Orit Sagi-Assif, Dina Kapon, Shay Hantisteanu, Tamar Burg, Pia Raanani, Abraham Avigdor, Isaac Ben-Bassat, Isaac P Witz
JournalOncogene (Oncogene) Vol. 22 Issue 48 Pg. 7649-60 (Oct 23 2003) ISSN: 0950-9232 [Print] England
PMID14576828 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • Mitogen-Activated Protein Kinases
  • Phosphoprotein Phosphatases
  • DUSP7 protein, human
  • Dual-Specificity Phosphatases
  • Protein Tyrosine Phosphatases
Topics
  • Cell Line, Tumor
  • Dual-Specificity Phosphatases
  • Gene Expression Regulation, Enzymologic
  • Humans
  • Leukemia, Myeloid (enzymology, pathology)
  • Leukocytes (enzymology, pathology)
  • Mitogen-Activated Protein Kinases (metabolism)
  • Phosphoprotein Phosphatases
  • Protein Tyrosine Phosphatases (genetics, metabolism)
  • RNA, Messenger (genetics, metabolism)
  • Signal Transduction
  • Substrate Specificity
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: